Activation of mesangial cell MAPK in response to homocysteine

被引:46
作者
Ingram, AJ
Krepinsky, JC
James, L
Austin, RC
Tang, DM
Salapatek, AM
Thai, K
Scholey, JW
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] Univ Texas, SW Med Ctr, Dept Med, Dallas, TX USA
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
基金
英国医学研究理事会;
关键词
mesangial cell; homocysteine; mitogen-activated protein kinase; signaling;
D O I
10.1111/j.1523-1755.2004.00795.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Alteration in mesangial cell function is central to the progression of glomerular disease in numerous models of chronic renal failure (CRF). Animal models of chronic glomerular disease are characterized by mesangial cell proliferation and elaboration of extracellular matrix protein (ECM), resulting in glomerulosclerosis. Elevated plasma levels of homocysteine (Hcy) are seen in both animal models and humans with CRF, and have been proposed to contribute to the high prevalence of vascular disease in this group. Some of the pathogenetic effects of Hcy are thought to be mediated via the induction of endoplasmic reticulum stress. Thus, Hcy effects on mesangial cells could contribute to the progression of CRF. Previous work has shown Hcy-mediated induction of Erk mitogen-activated protein kinase (MAPK) in vascular smooth muscle cells (VSMCs). Erk induces increases in activator protein-1 (AP-1) transcription factor activity which may augment mesangial cell proliferation and ECM protein production. Consequently, we studied the effect of Hcy on mesangial cell Erk signaling. Methods. Mesangial cells were exposed to Hcy after 24 hours of serum starvation and Erk activity assessed. Nuclear translocation of phospho-Erk was visualized by confocal microscopy. AP-1 nuclear protein binding was measured in response to Hcy by mobility shift assay. Hcy-induced mesangial cell calcium flux was measured in Fura-2 loaded cells. Mesangial cell DNA synthesis in response to Hcy was assessed by [H-3]-thymidine incorporation and proliferation by Western blotting for proliferating cell nuclear antigen (PCNA). Expression of endoplasmic reticulum stress response genes were determined by Northern and Western analysis. Results. Hcy led to an increase in Erk activity that was maximal at 50 mumol/L and 20 minutes of treatment. Subsequent experiments used this concentration and time point. Erk activity in response to Hcy was insensitive to n-acetylcysteine and catalase, indicating oxidative stress did not play a role. However, Hcy 50 mumol/L induced a brief increase in intracellular mesangial cell calcium within 5 minutes, and the calcium ionophores A23187 and ionomycin increased Erk activity while chelation of intracellular calcium with BAPTA-AM abrogated the Erk response to Hcy. Confocal microscopy of activated Erk nuclear translocation mirrored these results as did mesangial cell nuclear protein binding to AP-1 consensus sequences. Hcy-induced increases in thymidine incorporation and PCNA expression at 24 hours were Erk dependent. The expression of endoplasmic reticulum stress response genes was significantly elevated by Hcy in an Erk-dependent manner. Conclusion. Hcy increases Erk activity in mesangial cells via a calcium-dependent mechanism, resulting in increased AP-1 nuclear protein binding, cell DNA synthesis and proliferation and induction of endoplasmic reticulum stress. These observations suggest potential mechanisms by which Hcy may contribute to progressive glomerular injury.
引用
收藏
页码:733 / 745
页数:13
相关论文
共 70 条
[1]   MECHANICAL STRETCH/RELAXATION OF CULTURED RAT MESANGIAL CELLS INDUCES PROTOONCOGENES AND CYCLOOXYGENASE [J].
AKAI, Y ;
HOMMA, T ;
BURNS, KD ;
YASUDA, T ;
BADR, KF ;
HARRIS, RC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :C482-C490
[2]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[3]   Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro [J].
Aoki, H ;
Richmond, M ;
Izumo, S ;
Sadoshima, J .
BIOCHEMICAL JOURNAL, 2000, 347 :275-284
[4]   NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE [J].
BORDER, WA ;
NOBLE, NA ;
YAMAMOTO, T ;
HARPER, JR ;
YAMAGUCHI, Y ;
PIERSCHBACHER, MD ;
RUOSLAHTI, E .
NATURE, 1992, 360 (6402) :361-364
[5]   Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients - A prospective study [J].
Bostom, AG ;
Shemin, D ;
Verhoef, P ;
Nadeau, MR ;
Jacques, PF ;
Selhub, J ;
Dworkin, L ;
Rosenberg, IH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2554-2558
[6]   Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes [J].
Bostom, AG ;
Lathrop, L .
KIDNEY INTERNATIONAL, 1997, 52 (01) :10-20
[7]   NEPHRON ADAPTATION TO RENAL INJURY OR ABLATION [J].
BRENNER, BM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 249 (03) :F324-F337
[8]   HEMODYNAMICALLY MEDIATED GLOMERULAR INJURY AND THE PROGRESSIVE NATURE OF KIDNEY-DISEASE [J].
BRENNER, BM ;
KASSIRER, JP ;
MADIAS, NE ;
NARAYAN, G ;
HARRINGTON, JT .
KIDNEY INTERNATIONAL, 1983, 23 (04) :647-655
[9]   ERK2 activation by homocysteine in vascular smooth muscle cells [J].
Brown, JC ;
Rosenquist, TH ;
Monaghan, DT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 251 (03) :669-676
[10]   Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells:: activation of c-Jun NH2-terminal kinase and promoter response element [J].
Cai, Y ;
Zhang, C ;
Nawa, T ;
Aso, T ;
Tanaka, M ;
Oshiro, S ;
Ichijo, H ;
Kitajima, S .
BLOOD, 2000, 96 (06) :2140-2148